
    
      Single-center, multiple-dose study evaluting the local pharmacokinetics and tolerability of
      bimatoprost following 14 days of once daily topical administration of bimatoprost Formulation
      A and Formulation B (both containing 1% bimatoprost) to the scalp of male patients With
      androgenetic alopecia
    
  